Biomedical Chromatography 2008-08-01

Liquid chromatography/electrospray ionization tandem mass spectrometry for the quantification of mitiglinide in human plasma: validation and its application to pharmacokinetic studies.

Yan Zhang, Likun Ding, Yun Tian, Jing Yang, Lin Yang, Aidong Wen

Index: Biomed. Chromatogr. 22(8) , 873-8, (2008)

Full Text: HTML

Abstract

A sensitive and specific method was developed and validated for the determination of mitiglinide in human plasma using liquid chromatographic separation with electrospray ionization tandem mass spectrometric detection. Acidified plasma samples were extracted with ethyl acetate. The chromatographic separation was performed on an Agilent Zorbax Eclipse Plus C(18) column with a mobile phase of methanol-10 mm ammonium acetate solution at a flow rate of 0.3 mL/min. Analytes were detected with an Agilent 6410 Triple qudrupole mass spectrometer equipped with an electrospray ionization source in positive multiple reaction monitoring mode: m/z 316.2 (precursor ion) to 298.2 (product ion) for mitiglinide and m/z 318.2 (precursor ion) to 120.2 (product ion) for the internal standard. This method was validated over a linear range of 0.5-4000 ng/mL for mitiglinide in human plasma. The lower limit of quantification (LLOQ) was 0.5 ng/mL, while a relative standard deviation (RSD) was less than 3.9%. The intra- and inter-run precision (as RSD, %) obtained from three validation runs were all less than 15%. The validated method was successfully used to analyze human plasma samples for application in pharmacokinetic studies.Copyright (c) 2008 John Wiley & Sons, Ltd.


Related Compounds

Related Articles:

Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial.

2012-02-01

[Diabetes Obes. Metab. 14(2) , 187-9, (2012)]

Comparison of the rapidity of onset of the therapeutic effect between nateglinide and mitiglinide by PK/PD analysis in rats.

2012-03-01

[Eur. J. Drug Metab. Pharmacokinet. 37(1) , 9-15, (2012)]

Variations in tissue selectivity amongst insulin secretagogues: a systematic review.

2012-02-01

[Diabetes Obes. Metab. 14(2) , 130-8, (2012)]

Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.

2012-03-01

[Pharmacogenet. Genomics 22(3) , 206-14, (2012)]

Pleiotropic effects of mitiglinide in type 2 diabetes mellitus.

2009-01-01

[J. Int. Med. Res. 37(6) , 1904-12, (2009)]

More Articles...